US FDA Launches Rare Disease Drug Development Initiative
The US FDA has launched the Rare Disease Framework Initiative to develop a holistic, fit-for purpose framework for rare disease drug development.
US FDA Rare Disease Framework Initiative | 17/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy